pharma-company /Medicinal products /Active ingredients

Rx · PZN 19061872

TAKHZYRO 150 mg solution for injection in a pre-filled syringe

German trade nameTAKHZYRO 150 mg Injektionslösung in einer Fertigspritze

Active ingredientLanadelumabPharmaceutical formSolution for infusion

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €8,679

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for TAKHZYRO 150 mg solution for injection in a pre-filled syringe.

Review purchasing terms

TAKHZYRO 150 mg solution for injection in a pre-filled syringe contains the active ingredient Lanadelumab and comes as Solution for infusion. One pack size is recorded (PZN 19061872). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


TAKHZYRO 150 mg solution for injection in a pre-filled syringe was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.